It seems as if for every study on marijuana uses, there is another revelation that it does, in fact, have worthwhile medical applications. Another such study was recently published in the Journal of Neurology, Neurosurgery, and Psychiatry, where scientists found that a cannabis extract has positive effects on the treatment of multiple sclerosis (MS) symptoms.MS can be a debilitating disease, which has a variety of negative symptoms including muscle stiffness and pain and a subsequent difficulty sleeping. According to Medical News Today, about 90% of people diagnosed with MS have muscle pain and stiffness. It’s this pain, paired with the fact that many pharmaceutical solutions simply can’t relieve it without negative side effects, that “a growing number of MS patients have tried out alternative remedies and therapies, including cannabis.”
Compound in the plant does not produce psychoactive properties of cannabis
Found not only to stop breast cancer cells from acting ‘crazy’ but also to return to normal cells
A compound found in cannabis could halt the spread of many forms of aggressive cancer, scientists say.
Researchers found that the compound, called cannabidiol, had the ability to ‘switch off’ the gene responsible for metastasis in an aggressive form of breast cancer. Importantly, this substance does not produce the psychoactive properties of the cannabis plant.
The team from the California Pacific Medical Center, in San Francisco, first spotted its potential five years ago, after it stopped the proliferation of human breast cancer cells in the lab.
This is a documentary of how myself and others cured our cancers using an alternative and controversial treatment: cannabis oil. It’s a proven fact that CBD and THC, two of many components in cannabis, shrink tumors and cure cancer. This documentary shows my cancer being cured and explores the history and politics of cannabis and cancer. You will also see samples of many antique cannabis medicine bottles.
Medicinal marijuana oil made from cannabis buds, when ingested thrice daily, for two months, will destroy leukemia and cancer cells. Here is just one study which shows the results: http://www.ncbi.nlm.nih.gov/pubmed/16908594:
Plant-derived cannabinoids, including Delta9-tetrahydrocannabinol (THC), induce apoptosis in leukemic cells, although the precise mechanism remains unclear. In the current study, we investigated the effect of THC on the upstream and downstream events that modulate the extracellular signal-regulated kinase (ERK) module of mitogen-activated protein kinase pathways primarily in human Jurkat leukemia T cells. The data showed that THC down-regulated Raf-1/mitogen-activated protein kinase/ERK kinase (MEK)/ERK/RSK pathway leading to translocation of Bad to mitochondria. THC also decreased the phosphorylation of Akt. However, no significant association of Bad translocation with phosphatidylinositol 3-kinase/Akt and protein kinase A signaling pathways was noted when treated cells were examined in relation to phosphorylation status of Bad by Western blot and localization of Bad to mitochondria by confocal analysis. Furthermore, THC treatment decreased the Bad phosphorylation at Ser(112) but failed to alter the level of phospho-Bad on site Ser(136) that has been reported to be associated with phosphatidylinositol 3-kinase/Akt signal pathway. Jurkat cells expressing a constitutively active MEK construct were found to be resistant to THC-mediated apoptosis and failed to exhibit decreased phospho-Bad on Ser(112) as well as Bad translocation to mitochondria. Finally, use of Bad small interfering RNA reduced the expression of Bad in Jurkat cells leading to increased resistance to THC-mediated apoptosis. Together, these data suggested that Raf-1/MEK/ERK/RSK-mediated Bad translocation played a critical role in THC-induced apoptosis in Jurkat cells.